Spinomix (FibroTrap sample processing technology) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Spinomix (FibroTrap sample processing technology) General Information

Description

FibroTrap is a fibrinogen based sample processing technology. The technology is used for separation and concentration of target molecules from liquid samples within a simple, routine sample-collection tube. It is applicable to a wide variety of matrices such as blood, urine, swabs and food to isolate a large spectrum of targets such as bacteria, viruses and tumor cells and hence provides a breakthrough in sample processing applied to clinical diagnostics and the food industry.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Debiopharm Group
Primary Office
  • Innovation Square EPFL PSE-A
  • 1015 Lausanne
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Spinomix (FibroTrap sample processing technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Spinomix (FibroTrap sample processing technology)‘s full profile, request access.

Request a free trial

Spinomix (FibroTrap sample processing technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Spinomix (FibroTrap sample processing technology)‘s full profile, request access.

Request a free trial